Is Tartaric Acid safe in cosmetics?
Tartaric Acid has a safety rating of "EXCELLENT" in our database. EU status: permitted. US status: permitted. 6 toxicological study endpoint(s) are available in our database.
Also known as: L-(+)-Tartaric acid, d-alpha,beta-Dihydroxysuccinic acid, EINECS 201-766-0, Kyselina 2,3-dihydroxybutandiova, Kyselina vinna (+15 more)
INCI: TARTARIC ACID
Tartaric Acid (CAS 87-69-4) is a cosmetic cosmetic ingredient functioning as Dicarboxylic AHA (from grapes/wine). Historically significant as an AHA but. NOAEL 225 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: permitted. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 87-69-4 →
Tartaric Acid is classified GHS Danger (H302, H315, H317, H318, H319, H335) in the chemicals database but is allowed in EU cosmetics.
Source: Cosmetics: ingredients.eu_status; Chemicals: ghs_classifications.signal_word/hazard_statement_code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for Tartaric Acid.
Calculate MoS for your specific formulation with the MoS Calculator.
6 study endpoints found for Tartaric Acid. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | 181 mg/kg bw/day | oral | rat | Developmental | COSMOS_DB |
| NOAEL | 215 mg/kg bw/day | oral | rabbit | Developmental | COSMOS_DB |
| NOAEL | 225 mg/kg bw/day | oral | hamster | Developmental | COSMOS_DB |
| NOAEL | 274 mg/kg bw/day | oral | mouse | Developmental | COSMOS_DB |
| NOAEL | 990 mg/kg bw/day | oral | dog | Subchronic | COSMOS_DB |
| NOAEL | 1200 mg/kg bw/day | oral | rat | Chronic | COSMOS_DB |
Pre-calculated NOAEL → SED → MoS audit trail for Tartaric Acid across SCCS product categories, with measured dermal absorption where available.
Skin absorption and penetration characteristics of Tartaric Acid, relevant to systemic exposure and MoS calculations.
Source: CIR
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| NOAEL | =3100 mg/kg-day | Rat | oral | chronic | EFSA |
| ADI | <=30 mg/kg | Human | oral | - | WHO JECFA ADI |
| LD50 | >2000 mg/kg | Rat | dermal | acute | ECHA IUCLID |
| LD50 | ~4109 mg/kg | Mouse | oral | - | ECHA IUCLID |
| LD50 | >5000 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | >5000 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | =4109 mg/kg | Mouse | oral | - | ECHA IUCLID |
| LD50 | =920 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | >2000 mg/kg | Rat | oral | - | ECHA IUCLID |
| LD50 | ~920 mg/kg | Rat | oral | - | ECHA IUCLID |
Adverse Outcome Pathway data across 5 assays (DPRA, KeratinoSens, hCLAT, LLNA, NESIL) aggregated from public sources.
Source: DPRA: Bauch et al. 2012 [DOI:10.1016/j.yrtph.2012.05.013] | Jaworska 2011 [DOI:10.1002/jat.2869]; KS: Emter et al. 2010 [DOI:10.1016/j.taap.2010.03.009] | Bauch et al. 2012 [DOI:10.1016/j.yrtph.2012.05.013]; hCLAT: Bauch et al. 2012 [DOI:10.1016/j.yrtph.2012.05.013]
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| CN | restricted | 6 | Rinse-off and leave-on products |
10 property records from structured ingredient metadata.
Expert safety assessment and concern-level summary for Tartaric Acid.
Public NOAEL study rows linked to Tartaric Acid by CAS number or substance name.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
Tartaric Acid has a safety rating of "EXCELLENT" in our database. EU status: permitted. US status: permitted. 6 toxicological study endpoint(s) are available in our database.
Tartaric Acid EU regulatory status: permitted. This is based on EU Regulation 1223/2009 and its amendments.
Tartaric Acid functions as: Dicarboxylic AHA (from grapes/wine). Historically significant as an AHA but less stable than glycolic or lactic acid, making it uncommon as a primary exfoliant in modern formulations. More frequently employed as a pH adjuster, chelating agent, and mild exfoliating co-ingredient in combination peels. Contributes synergistic exfoliation in combination acid peels.. It is classified as a cosmetic ingredient in our database. CAS number: 87-69-4.
The NOAEL (No Observed Adverse Effect Level) for Tartaric Acid is 181 mg/kg bw/day based on a Developmental study via oral route in rat. A total of 6 study endpoints are available. Source: COSMOS_DB.
Tartaric Acid also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
Tartaric Acid is classified GHS Danger (H302, H315, H317, H318, H319, H335) in the chemicals database but is allowed in EU cosmetics.
Check Tartaric Acid compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Tartaric Acid in your formulation.